The American medical system's emphasis on 15-minute visits and efficiency incentivizes prescribing medication to treat symptoms rather than unraveling root causes. This approach aims to "polish the hood when there's a problem in the engine."

While long shifts seem to ensure continuous care by keeping one doctor with patients longer, they have the opposite effect. Exhausted physicians focus only on immediate tasks, creating a "just covering" mentality. This prevents long-term ownership, leading to a revolving door of providers and fragmented care day-over-day.

Simple text reminders for medication adherence are common. The real opportunity is using two-way, AI-powered texting to create conversations that uncover the specific reasons (out of over 250 identified) why a patient might stop taking their medication, allowing for timely and personalized interventions.

The friction of navigating insurance and pharmacies is so high that chronic disease patients often give up, skipping tests or medications and directly worsening their health. AI can automate these tedious tasks, removing the barriers that lead to non-compliance and poor health outcomes.

Effective healthcare requires connections far beyond the doctor and patient. A truly connected system integrates caregivers with management, the hospital with the patient, the patient with their community, and the entire system with government bodies. Operating in silos guarantees failure.

The structured support from nurses and doctors abruptly stops after major treatments like chemotherapy conclude. This creates a feeling of being orphaned, as patients lose their primary point of contact for ongoing side effects and fears, highlighting a critical gap in long-term survivorship care.

The dominant "fee-for-service" payment model commodifies primary care into discrete office visits. It fails to reimburse doctors for crucial work like communicating with specialists or following up on tests. This forces high patient volumes and short appointments, undermining the physician's role as the safekeeper of a patient's full medical story.

Chronic disease patients face a cascade of interconnected problems: pre-authorizations, pharmacy stockouts, and incomprehensible insurance rules. AI's potential lies in acting as an intelligent agent to navigate this complex, fragmented system on behalf of the patient, reducing waste and improving outcomes.

Walgreens prioritizes tackling barriers to medication access—such as cost and prior authorizations—believing that adherence can only be addressed once a patient can consistently obtain their therapy. This frames the two issues as a sequence, not parallel challenges.